17 February 2022: The Board of Directors of Aker BioMarine ASA (the "Company") has resolved to implement a share purchase program for employees in the Company and its Norwegian subsidiaries (the "Employee Share Purchase Program"), on the basis of the authorisation granted to the Board of Directors by the annual general meeting of the Company on 12 March 2021.
The participants in the Employee Share Purchase Program will be offered to acquire new shares in the Company for an amount of between NOK 5,000 and NOK 60,000 each. The shares will be offered at a price based on the volume weighted average share price for the Company's shares on the Oslo Stock Exchange during the last five trading days prior to, and including, the last day of the application period, with a discount of 20% on the aggregate investment amount. Any shares acquired in the Employee Share Purchase Program will be subject to a lock-up period of two years, and the reduced offer price shall reflect the value-reducing effect of the lock-up period.
The application period in the Employee Share Purchase Program commences today, on 17 February 2022, at 09:00 hours (CET) and expires at 16:30 hours (CET) on 28 February 2022. Shares acquired in the offer will be settled in the form of new shares in the Company to be issued pursuant to the authorisation granted to the Board of Directors by the annual general meeting held on 12 March 2021.
For further information, please contact
Carl Christian Bachke, Investor Relations
Mobile: +47 909 808 48
Email: carl.bachke@akerbiomarine.com
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.
About Aker BioMarine
Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting company developing krill-derived products for pharma, consumer health and wellness as well as animal nutrition. The company has a strong position in its industry and is the world's leading supplier of krill, the natural, powerful and health promoting source of nutrients from the pristine waters of Antarctica. Aker BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.